Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Net deposit increase | 97.44%40.64B | 83.55%31.83B | 561.39%30.07B | 105.66%28.24B | 157.90%20.58B | 19,276.94%17.34B | 421.04%4.55B | -73.33%13.73B | -72.84%7.98B | -99.61%89.5M |
| Net increase in borrowings from central bank | --10.37B | --7.13B | --5.25B | ---- | ---- | ---- | ---- | 187.79%17.11B | 383.63%15.75B | 190.88%8.67B |
| Cash received from interests, fees and commissions | 16.04%14.74B | 13.32%9.31B | 12.52%4.37B | 1.46%16.83B | 3.18%12.7B | 4.41%8.21B | 1.50%3.88B | 15.59%16.59B | 11.86%12.31B | 10.12%7.87B |
| Net increase in repurchase business capital | 77.26%5.19B | -47.94%6.3B | ---- | --230M | --2.93B | --12.1B | --14.9B | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | ---- | ---- | --398.41M | ---- | ---- | --272.59M | ---- | ---- | --51.87M |
| Cash received relating to other operating activities | 177.54%9M | 222.04%6.72M | -99.76%1.27M | 6,030.56%1.4B | -52.75%3.24M | -6.75%2.09M | 128,179.90%536.21M | 38.55%22.89M | -46.23%6.86M | -80.73%2.24M |
| Cash inflows from operating activities | 98.95%74.55B | 49.90%58B | 53.95%41.03B | -1.76%49.47B | -0.86%37.47B | 103.43%38.69B | 150.47%26.65B | -34.38%50.36B | -14.07%37.8B | -43.71%19.02B |
| Staff behalf paid | 1.02%837.9M | 3.20%605.78M | 5.89%378.1M | -6.14%1.08B | -4.49%829.48M | 6.95%587.02M | 10.96%357.08M | 9.41%1.15B | 12.83%868.47M | 3.71%548.85M |
| All taxes paid | 35.06%905.44M | 23.08%579.06M | 21.42%286.43M | -11.63%914.55M | -15.58%670.39M | -6.88%470.49M | 2.86%235.89M | -20.52%1.03B | -21.46%794.11M | -31.14%505.24M |
| Net loan and advance increase | 265.42%65.04B | 348.73%54.67B | 119.03%30.5B | 146.43%35.31B | 119.60%17.8B | 25.79%12.18B | 104.81%13.92B | 35.54%14.33B | 0.91%8.11B | 40.47%9.69B |
| Net deposit in central bank and institutions | 105.34%1.41B | 155.19%1.32B | 998.26%426.47M | 94.61%1.01B | 4,370.22%687.92M | --515.5M | -69.26%38.83M | -49.74%521.05M | -97.56%15.39M | ---- |
| Net lend capital | ---- | ---- | ---- | -69.50%970M | -41.57%1.04B | ---- | ---- | 218.15%3.18B | 78.09%1.78B | -51.98%480M |
| Cash paid for fees and commissions | -15.88%5.85B | -6.45%4.48B | 4.87%2.43B | 37.01%9.44B | 42.05%6.95B | 43.62%4.79B | 58.41%2.31B | 29.93%6.89B | 27.44%4.89B | 29.69%3.33B |
| Net increase in financial assets held for trading purposes | -50.99%1.2B | ---- | --1.52B | 467.29%1.88B | 25.28%2.44B | 35.33%1.73B | ---- | -91.41%331.18M | --1.95B | --1.28B |
| Cash paid relating to other operating activities | 262.49%2.11B | 300.81%1.36B | 1,111.28%1.83B | -27.28%734.32M | 22.03%582.79M | 6.16%340.5M | -4.61%150.87M | 86.65%1.01B | -25.36%477.58M | 24.78%320.73M |
| Cash outflows from operating activities | 78.94%77.54B | 48.91%63.62B | 1.38%38.02B | 60.27%60.95B | 63.80%43.33B | 115.24%42.72B | 153.86%37.51B | 54.23%38.03B | 40.94%26.46B | 56.00%19.85B |
| Net cash flows from operating activities | 48.99%-2.99B | -39.43%-5.62B | 127.72%3.01B | -193.13%-11.48B | -151.68%-5.86B | -386.37%-4.03B | -162.59%-10.85B | -76.33%12.33B | -55.02%11.34B | -103.93%-828.37M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 57.73%46.33B | 26.61%27.57B | 60.71%13.67B | -36.46%41.13B | -37.42%29.37B | -29.16%21.78B | -33.32%8.51B | 75.57%64.73B | 138.75%46.94B | 80.34%30.74B |
| Cash received from returns on investments | 47.38%821.76M | 114.74%808.25M | 1.67%72.04M | 45.36%1.33B | -0.50%557.58M | -9.44%376.39M | -57.30%70.86M | 38.48%917.96M | 65.73%560.36M | 43.50%415.64M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | -94.70%460K | 32.00%297K | -96.02%286K | 184.48%8.87M | 2,692.28%8.68M | -54.36%225K | 5,694.35%7.19M | 1,025.99%3.12M | 101.95%311K | 971.74%493K |
| Special items of investing cash inflows | ---- | ---- | ---- | -0.37%4.62M | ---- | ---- | ---- | -27.50%4.64M | ---- | ---- |
| Cash inflows from investing activities | 57.49%47.15B | 28.11%28.38B | 60.09%13.74B | -35.30%42.48B | -36.97%29.94B | -28.90%22.15B | -33.57%8.58B | 74.90%65.65B | 137.51%47.5B | 79.73%31.16B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -45.06%22.59M | -53.31%10.62M | -96.90%576K | 15.40%56.69M | 50.27%41.12M | 31.38%22.73M | 194.04%18.59M | 22.22%49.13M | 0.19%27.37M | 35.94%17.3M |
| Cash paid to acquire investments | 21.31%37.17B | -13.31%20.71B | 17.51%9.96B | -11.86%54.44B | -33.85%30.64B | -21.24%23.89B | -43.97%8.47B | -27.42%61.77B | 31.23%46.33B | 41.42%30.33B |
| Cash outflows from investing activities | 21.22%37.2B | -13.35%20.72B | 17.26%9.96B | -11.84%54.5B | -33.80%30.68B | -21.21%23.91B | -43.87%8.49B | -27.40%61.82B | 31.20%46.35B | 41.42%30.34B |
| Net cash flows from investing activities | 1,435.64%9.96B | 536.59%7.66B | 3,990.96%3.79B | -413.54%-12.02B | -164.99%-745.49M | -315.92%-1.76B | 104.20%92.53M | 108.05%3.83B | 107.48%1.15B | 119.73%812.92M |
| Financing cash flow | ||||||||||
| Cash from bonds issue | 0.53%76.86B | 10.55%52.34B | -6.63%24.46B | 31.86%116.66B | 17.41%76.46B | -8.06%47.34B | 11.92%26.19B | 22.63%88.47B | 85.61%65.12B | 296.12%51.5B |
| Cash received from the issuance of other equity instruments | --5B | --5B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash inflows from financing activities | 7.07%81.86B | 21.11%57.34B | -6.63%24.46B | 31.86%116.66B | 17.41%76.46B | -8.06%47.34B | 11.92%26.19B | 22.63%88.47B | 85.61%65.12B | 296.12%51.5B |
| Borrowing repayment | -8.74%68.31B | -0.82%44.57B | -3.05%18.43B | 4.73%95.06B | 11.72%74.85B | 2.70%44.94B | 5.20%19.01B | 15.78%90.77B | 33.81%67B | 32.97%43.76B |
| Dividend interest payment | 57.46%592.82M | -0.89%162.41M | -0.67%76.28M | -57.66%376.99M | -57.71%376.48M | -78.73%163.87M | 1.49%76.8M | -17.09%890.5M | -11.21%890.28M | -10.97%770.39M |
| Cash payments relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -2.41%100.38M | 9.83%68.36M |
| Special items of financing cash outflows | 0.27%97.32M | 6.87%65.68M | 13.15%30.37M | -3.73%128.61M | --97.06M | --61.46M | --26.84M | --133.59M | ---- | ---- |
| Cash outflows from financing activities | -8.39%69B | -0.81%44.8B | -3.02%18.54B | 4.11%95.57B | 10.79%75.32B | 1.27%45.17B | 5.20%19.11B | 15.30%91.79B | 32.86%67.99B | 31.80%44.6B |
| Net cash flows from financing activities | 1,035.34%12.86B | 475.29%12.54B | -16.37%5.92B | 734.75%21.09B | 139.42%1.13B | -68.40%2.18B | 35.24%7.08B | 55.48%-3.32B | 82.14%-2.87B | 133.11%6.9B |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 462.21%19.83B | 504.61%14.58B | 445.50%12.71B | -118.77%-2.41B | -156.93%-5.47B | -152.37%-3.6B | -233.74%-3.68B | 528.92%12.84B | 254.89%9.62B | 276.84%6.88B |
| Add:Begin period cash and cash equivalents | -7.86%28.25B | -7.86%28.25B | -7.86%28.25B | 72.05%30.66B | 72.05%30.66B | 72.05%30.66B | 72.05%30.66B | -14.38%17.82B | -14.38%17.82B | -14.38%17.82B |
| End period cash equivalent | 90.91%48.08B | 58.33%42.83B | 51.85%40.96B | -7.86%28.25B | -8.21%25.18B | 9.51%27.05B | 61.38%26.98B | 72.05%30.66B | 87.85%27.43B | 46.00%24.7B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.